Geriatric functional assessment for decisionmaking on adjuvant chemotherapy in older colon cancer patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Despite the increasing need for geriatric assessment prior to chemotherapy, the method for this assessment remains inadequate for older cancer patients. We aimed to propose a simple assessment method to predict the performance of adjuvant chemotherapy in older patients after colon cancer surgery. Methods: This prospective study included patients over 65 years of age who were scheduled for adjuvant chemotherapy after colon cancer surgery. Before initiating chemotherapy, their functional status was assessed on the basis of activities of daily living (ADL)/instrumental activities of daily living (IADL). These parameters were analyzed with clinical characteristics and the patterns of adjuvant chemotherapy. The focus was on the completion rate of adjuvant chemotherapy. Results: A total of 89 patients with a median age of 72 years were analyzed. Among them, 54 (61%) were non-impaired and 35 (39%) were impaired regarding their ADL/IADL classification. Low body mass index and impairment of ADL/IADLs were significantly associated with chemotherapy interruption. Among toxicities, fatigue and hand-foot syndrome were independent prognostic factors for chemotherapy interruption. Impairments of ADL/IADL were significantly associated with fatigue regardless of age. Based on age and ADL/IADL stratification, younger patients (≤ 72 years) and/or those who were ADL/IADL non-impaired were significantly more likely to complete adjuvant chemotherapy than older patients (> 72 years) and ADL/IADL impaired patients (p = 0.038). This was regardless of the chemotherapy regimen. Conclusions: Functional assessment using ADL/IADL is a convenient method to predict chemotherapy toxicity and performance. These results suggested that routine screening for ADL/IADLs could guide appropriate patient selection for the completion of adjuvant chemotherapy and predict expected outcomes.
Abstract
Background/Aims: Despite the increasing need for geriatric assessment prior to chemotherapy, the method for this assessment remains inadequate for older cancer patients. We aimed to propose a simple assessment method to predict the performance of adjuvant chemotherapy in older patients after colon cancer surgery. Methods: This prospective study included patients over 65 years of age who were scheduled for adjuvant chemotherapy after colon cancer surgery. Before initiating chemotherapy, their functional status was assessed on the basis of activities of daily living (ADL)/instrumental activities of daily living (IADL). These parameters were analyzed with clinical characteristics and the patterns of adjuvant chemotherapy. The focus was on the completion rate of adjuvant chemotherapy. Results: A total of 89 patients with a median age of 72 years were analyzed. Among them, 54 (61%) were non-impaired and 35 (39%) were impaired regarding their ADL/IADL classification. Low body mass index and impairment of ADL/IADLs were significantly associated with chemotherapy interruption. Among toxicities, fatigue and hand-foot syndrome were independent prognostic factors for chemotherapy interruption. Impairments of ADL/IADL were significantly associated with fatigue regardless of age. Based on age and ADL/IADL stratification, younger patients (≤ 72 years) and/or those who were ADL/IADL non-impaired were significantly more likely to complete adjuvant chemotherapy than older patients (> 72 years) and ADL/IADL impaired patients (p = 0.038). This was regardless of the chemotherapy regimen. Conclusions: Functional assessment using ADL/IADL is a convenient method to predict chemotherapy toxicity and performance. These results suggested that routine screening for ADL/IADLs could guide appropriate patient selection for the completion of adjuvant chemotherapy and predict expected outcomes.
참고문헌 (30)
- "Cancer statistics reports for Korea" (2017)[URL]
- "7th Colon cancer assessment report" (2020)[URL]
- "SEER Cancer Statics Review, 2013-2017" (2017)[URL]
- Haller DG, "Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer : a pooled analysis of individual patient data from four randomized, controlled trials", Ann Oncol, 26, pp.715~724 (2015)
- Andre T, "Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer", N Engl J Med, 350, pp.2343~2351 (2004)
- Haller DG, "Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer", J Clin Oncol, 29, pp.1465~1471 (2011)
- Cheung WY, "Determinants of early mortality among 37, 568 patients with colon cancer who participated in 25 clinical trials from the adjuvant colon cancer endpoints database", J Clin Oncol, 34, pp.1182~1189 (2016)
- SanoffHK, "Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years", J Clin Oncol, 30, pp.2624~2634 (2012)
- Bouchardy C, "Undertreatment strongly decreases prognosis of breast cancer in elderly women", J Clin Oncol, 21, pp.3580~3587 (2003)
- Li D, "Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy", J Cancer Res Clin Oncol, 144, pp.909~923 (2018)
- Green SL, "The use of chemotherapy in older patients with stage II and III colon cancer : variation by age and era of diagnosis", J Geriatr Oncol, 10, pp.132~137 (2019)
- Extermann M, "Predicting the risk of chemotherapy toxicity in older patients : the Chemotherapy Risk Assessment Scale for High-Age Patients(CRASH)score", Cancer, 118, pp.3377~3386 (2012)
- "NCCN Clinical Practice Guidelines for specific populations: Older Adult Oncology (version 1.2020)" (2020)[URL]
- Papamichael D, "Treatment of colorectal cancer in older patients : International Society of Geriatric Oncology(SIOG)consensus recommendations 2013", Ann Oncol, 26, pp.463~476 (2015)
- Wildiers H, "International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer", J Clin Oncol, 32, pp.2595~2603 (2014)
- Mohile SG, "Practical assessment and management of vulnerabilities in older patients receiving chemotherapy : ASCO guideline for geriatric oncology summary", J Oncol Pract, 14, pp.442~446 (2018)
- Hurria A, "Predicting chemotherapy toxicity in older adults with cancer : a prospective multicenter study", J Clin Oncol, 29, pp.3457~3465 (2011)
- Katz S, "Studies of illness in the aged : the index of ADL : a standardized measure of biological and psychosocial function", JAMA, 185, pp.914~919 (1963)
- Lawton MP, "Assessment of older people : self-maintaining and instrumental activities of daily living", Gerontologist, 9, pp.179~186 (1969)
- Aparicio T, "Geriatric factors predict chemotherapy feasibility : ancillary results of FFCD 2001-02phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients", J Clin Oncol, 31, pp.1464~1470 (2013)
- Won CW, "The development of Korean activities of daily living(K-ADL)and Korean instrumental activities of daily living(K-IADL)scale", J Korean Geriatr Soc, 6, pp.107~120 (2002)
- Inouye SK, "Importance of functional measures in predicting mortality among older hospitalized patients", JAMA, 279, pp.1187~1193 (1998)
- Lee DW, "Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients : results from the AVANT trial", Sci Rep, 10, pp.19467~ (2020)
- Martin L, "Diagnostic criteria for the classification of cancer-associated weight loss", J Clin Oncol, 33, pp.90~99 (2015)
- Bruijnen CP, "Predictive value of each geriatric assessment domain for older patients with cancer : a systematic review", J Geriatr Oncol, 10, pp.859~873 (2019)
- Hamaker ME, "The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer", Oncologist, 17, pp.1439~1449 (2012)
- Kim JW, "A novel geriatric screening tool in older patients with cancer : the Korean Cancer Study Group Geriatric Score(KG)-7", PLoS One, 10, pp.e0138304~ (2015)
- Fabi A, "Cancer-related fatigue:ESMO Clinical Practice Guidelines for diagnosis and treatment", Ann Oncol, 31, pp.713~723 (2020)
- Extermann M, "Use of comprehensive geriatric assessment in older cancer patients : recommendations from the task force on CGA of the International Society of Geriatric Oncology(SIOG)", Crit Rev Oncol Hematol, 55, pp.241~252 (2005)
- Twelves C, "Capecitabine as adjuvant treatment for stage III colon cancer", N Engl J Med, 352, pp.2696~2704 (2005)